نصیرآبادی, نرسی and برزیکار, مهدی and فدایی حیدری, نسترن (1391) بررسي مقاومت أنتي بيوتيكي سوش باكتريايي سودوموناس آئروژينوزا (Pseudomonas aeruginosa). در: The 13th Iranian & The Second International Congress of Microbiology, July 14 – 16, 2012, Ardabil - Iran.
|
Text
- Published Version
263kB |
Official URL: http://congress.arums.ac.ir/index.php/IICM/5/sched...
Title
Study of Antibiotic Resistance in Pseudomonas aeruginosa Strains
English Abstract
Background & Objectives: More than half of all clinical isolates produce the blue-green pigment pyocyanin. These pathogens are widespread in nature, inhabiting soil, water, plants, and animals (including humans). Pseudomonas aeruginosa has become an important cause of infection, especially in patients with compromised host defense mechanisms. Biofilms, communities of cells adhering to a substratum, likely represent the prevalent form of microorganisms in nature. Resistance to antimicrobials is a general feature of all biofilms that are the major cause of recalcitrant infections. Biofilms might be responsible for 65% of all bacterial infections. One obvious difference between planktonic cells and biofilm is the presence of a polysaccharide matrix enveloping the community that retards diffusion of antimicrobials into the biofilm. Methods: Strains isolated from various clinical specimens November 2010 from Amam Ahvaz Hospital, Iran. The bacteria were grown in Luria-Bertani (LB) broth or LB agar containing the appropriate antibiotics. All samples were subjected to disk diffusion susceptibility testing Minimum Inhibitory Concentrations of piperacillin, cefoperazone,ceftazidime, cefotaxime, cefepime, imipenem, meropenem, gentamicin, amikacin, tobramycin,and ciprofloxacin for 100 Pseudomonas aeruginosa strains isolated. Results: Pseudomonas aeruginosa strains were the most sensitive to ceftazidime (78.9%),imipenem (73.6%), meropenem (70.9%) and the most resistant to gentamicin (54.1%) and ciprofloxacin (52.5%). Conclusion: Multi-drug resistant Pseudomonas aeruginosa nosocomal infections are increasingly recognized worldwide. aminoglycosides (gentamicin, amikacin, tobramycin), quinolones (ciprofloxacin, levofloxacin, but not moxifloxacin),cephalosporins (ceftazidime, cefepime, cefoperazone, cefpirome, but not cefuroxime, ceftriaxone, cefotaxime), antipseudomonal penicillins: ureidopenicillins and carboxypenicillins (piperacillin, ticarcillin: P. aeruginosa is intrinsically resistant to all other penicillins),carbapenems (meropenem, imipenem, doripenem, but not ertapenem), polymyxins (polymyxin B and colistin), monobactams (aztreonam). The risk of emergence of antibiotic resistance may vary with different antibiotic treatments.
Item Type: | Conference or Workshop Item (Poster) |
---|---|
زبان سند : | انگلیسی |
نویسنده مسئول : | نرسی نصیرآبادی |
کلیدواژه ها (انگلیسی): | Antibiotic Resistance ; Pseudomonas aeruginosa ; Clinical Isolates |
Subjects: | QV pharmacology QW Microbiology and Immunology |
Divisions: | Vice Chancellor for Research and Technology > Deputy for Research and Technology management and Medical Information > University of Management Conferences and Congresses |
ID Code: | 4717 |
Deposited By: | MS Soghra Golmaghani |
Deposited On: | 08 Jul 1392 12:57 |
Last Modified: | 08 Jul 1392 12:57 |
Repository Staff Only: item control page